학술논문
1085O Atezolizumab, bevacizumab, and cobimetinib (TACo) in patients (pts) with PD1 refractory melanoma brain metastases (MBM)
Document Type
Abstract
Author
Source
In Annals of Oncology October 2023 34 Supplement 2:S652-S653
Subject
Language
ISSN
0923-7534